Airsculpt Technologies Inc
NASDAQ:AIRS

Watchlist Manager
Airsculpt Technologies Inc Logo
Airsculpt Technologies Inc
NASDAQ:AIRS
Watchlist
Price: 2.64 USD -2.58% Market Closed
Market Cap: $164.8m

Airsculpt Technologies Inc
Investor Relations

AirSculpt Technologies, Inc. operates as a blank check company. The company is headquartered in Miami Beach, Florida and currently employs 240 full-time employees. The company went IPO on 2021-10-29. The firm's activities are conducted through the Professional Associations and its wholly owned subsidiaries, which owns and operates the non-clinical assets and provide management services. The company offers patients a range of customized body contouring procedures, including fat removal and fat transfer. The firm also offers fat transfer procedures that uses the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its fat transfer procedures include Power Brazilian Butt Lift (BBL), a Brazilian butt lift procedure; Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. The firm also leverages AirSculpt TV, which allows viewers into procedure rooms to watch its surgeons use AirSculpt body contouring procedure. The company operates in approximately 16 centers across 13 states.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Apr 2, 2026
AI Summary
Q4 2025

Revenue: Fourth-quarter revenue was $33.4 million, down about 15% year over year, as lower case volume reflected a tougher consumer spending backdrop.

Profitability: Adjusted EBITDA rose to $2.5 million, or 7.4% of revenue, helped by higher gross margin and tighter SG&A.

Turnaround: Management said the business stabilized in 2025 and turned to positive same-store sales growth in February 2026, with March trends also improving.

New services: AirSculpt is leaning into GLP-1-related demand with skin tightening and a new skin removal pilot; more than 100 skin removal surgeries were completed in Q4.

Balance sheet: The company reduced debt, ended the year with leverage below 3x, and said it expects to refinance the term loan while targeting net debt leverage below 2.5x.

2026 outlook: Revenue guidance is $151 million to $157 million and adjusted EBITDA guidance is $15 million to $17 million; no new center openings are assumed this year.

Key Financials
Revenue
$33.4 million
Same-store revenue
down 16%
Adjusted EBITDA
$2.5 million
Adjusted EBITDA margin
7.4%
Gross margin
approximately 59%
Cost of services
$13.7 million
SG&A
approximately $18.2 million
Customer acquisition cost
roughly $3,300 per case
Full-year revenue
$151.8 million
Full-year adjusted EBITDA
approximately $15 million
Cash
$8.4 million
Gross debt outstanding
$56 million
Debt repaid in 2025
$19 million
Debt repaid over last 5 quarters
over $30 million
Leverage ratio
below 3x
Cash flow from operations
$3.1 million
ATM proceeds in Q1
$14.8 million
Debt principal paid in Q1
$11 million
Skin removal surgeries in Q4
more than 100
Earnings Call Recording
Other Earnings Calls

Management

Dr. Aaron J. Rollins M.D.
Founder & Executive Chairman
No Bio Available
Mr. Dennis Dean CPA
Interim CEO & CFO
No Bio Available
Mr. Todd Magazine
Advisor
No Bio Available
Mr. Philip Bodie
Chief Accounting Officer
No Bio Available
Stephanie Evans Greene
Chief Marketing Officer
No Bio Available

Contacts

Address
FLORIDA
Miami Beach
400 Alton Road, Unit Th-103M, Unit Th-103m
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett